| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 20.26% | Truist Securities | $33 → $39 | Maintains | Hold |
| 10/16/2023 | 29.51% | Leerink Partners | → $42 | Initiates Coverage On | → Outperform |
| 09/21/2023 | 20.26% | Truist Securities | → $39 | Reiterates | Hold → Hold |
| 09/21/2023 | 35.68% | Stephens & Co. | → $44 | Reiterates | Overweight → Overweight |
| 09/21/2023 | 37.22% | HC Wainwright & Co. | $41 → $44.5 | Maintains | Buy |
| 08/08/2023 | 20.26% | BTIG | → $39 | Upgrades | Neutral → Buy |
| 08/03/2023 | 20.26% | Truist Securities | $42 → $39 | Maintains | Hold |
| 08/03/2023 | 26.43% | HC Wainwright & Co. | $37 → $41 | Maintains | Buy |
| 07/19/2023 | 29.51% | Truist Securities | $36 → $42 | Maintains | Hold |
| 05/11/2023 | 11.01% | Truist Securities | $31 → $36 | Maintains | Hold |
| 05/11/2023 | 29.51% | Stephens & Co. | $39 → $42 | Maintains | Overweight |
| 02/27/2023 | -4.41% | Truist Securities | $29 → $31 | Maintains | Hold |
| 01/31/2023 | -10.58% | Truist Securities | $25 → $29 | Maintains | Hold |
| 01/27/2023 | 14.09% | HC Wainwright & Co. | → $37 | Reiterates | → Buy |
| 01/03/2023 | 14.09% | HC Wainwright & Co. | $35 → $37 | Maintains | Buy |
| 12/20/2022 | -22.91% | Truist Securities | $22 → $25 | Maintains | Hold |
| 11/10/2022 | 7.92% | HC Wainwright & Co. | $53 → $35 | Maintains | Buy |
| 11/10/2022 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/18/2022 | 4.84% | BTIG | $45 → $34 | Maintains | Buy |
| 02/25/2022 | 38.76% | SVB Leerink | $40 → $45 | Maintains | Outperform |
| 12/21/2021 | 60.35% | Truist Securities | $55 → $52 | Maintains | Buy |
| 08/05/2021 | 91.18% | SVB Leerink | $67 → $62 | Maintains | Outperform |
| 05/06/2021 | 100.43% | HC Wainwright & Co. | $60 → $65 | Maintains | Buy |
| 02/25/2021 | 85.01% | HC Wainwright & Co. | $44 → $60 | Maintains | Buy |
| 02/25/2021 | 85.01% | SVB Leerink | $50 → $60 | Maintains | Outperform |
| 01/12/2021 | 35.68% | HC Wainwright & Co. | $26 → $44 | Maintains | Buy |
| 01/11/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 12/18/2020 | -4.41% | Stephens & Co. | → $31 | Initiates Coverage On | → Overweight |
| 10/19/2020 | -7.49% | BTIG | $23 → $30 | Maintains | Buy |
| 10/15/2020 | -19.83% | HC Wainwright & Co. | $22 → $26 | Maintains | Buy |
| 10/12/2020 | -7.49% | SVB Leerink | $20 → $30 | Maintains | Outperform |
| 09/17/2020 | -25.99% | Truist Securities | → $24 | Initiates Coverage On | → Buy |
| 04/03/2020 | -35.25% | BTIG | $24 → $21 | Maintains | Buy |
| 02/03/2020 | -32.16% | HC Wainwright & Co. | $21 → $22 | Reiterates | → Buy |
| 10/09/2019 | -41.41% | HC Wainwright & Co. | → $19 | Initiates Coverage On | → Buy |
| 02/28/2019 | — | Needham | Downgrades | Buy → Hold | |
| 01/29/2019 | -29.08% | Oppenheimer | → $23 | Initiates Coverage On | → Outperform |
What is the target price for Vericel (VCEL)?
The latest price target for Vericel (NASDAQ: VCEL) was reported by Truist Securities on November 9, 2023. The analyst firm set a price target for $39.00 expecting VCEL to rise to within 12 months (a possible 20.26% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vericel (VCEL)?
The latest analyst rating for Vericel (NASDAQ: VCEL) was provided by Truist Securities, and Vericel maintained their hold rating.
When is the next analyst rating going to be posted or updated for Vericel (VCEL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vericel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vericel was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Vericel (VCEL) correct?
While ratings are subjective and will change, the latest Vericel (VCEL) rating was a maintained with a price target of $33.00 to $39.00. The current price Vericel (VCEL) is trading at is $32.43, which is out of the analyst's predicted range.